Immobilized artificial membrane (IAM) liquid chromatography as a model for antimicrobial peptide partitioning into cell membranes: An evaluation
DOI:
https://doi.org/10.29173/eureka8021Abstract
Non-covalent immobilized artificial membrane reverse-phase high performance liquid chromatography was previously evaluated as a means whereby elution times for antimicrobial peptides from columns mimicking the lipid bilayers of different membrane systems might be used as a fast-screening method to compare relative binding effectiveness. Such a system would aid in the development of antimicrobial peptides that bind preferentially to model pathogenic systems and leave the host’s membranes reasonably unaffected. A non-covalent approach allows for flexibility in membrane composition but was found to be inadequate for analysis of most peptides due to significant lipid loss at high acetonitrile concentrations. A covalent approach where phosphatidylcholine was amide-linked to the silica surface was examined to evaluate its use as a fast-screening method and compare its data to that collected from the non-covalent columns. Initial work with a 1-cm column proved ineffective due to problems with balancing flow rates with retention times, and work was shifted to a longer 10-cm column. Results suggested that peptides bind much more strongly to covalent columns than non-covalent ones, with the binding especially enhanced by the presence of cationic residues. These columns had lipid packing densities much lower than true membranes, indicating that the peptides were partitioning deep into the bonded phase of the columns rather than into the interfacial region of the phosphate head groups, as expected in situations of biologically-relevant lipid packing densities.Downloads
Downloads
Published
How to Cite
Issue
Section
License
By signing the Eureka publication agreement, authors agree to the following:
- The work has not been previously published in any format;
- Eureka is granted the royalty-free right to publish and disseminate the work in current and future formats;
- The work will be published in Eureka under a Creative Commons license. Eureka encourages authors to publish the work under a Creative Commons Attribution 4.0 International license (CC BY 4.0) that allows others to distribute, tweak, and build upon the work, even commercially, as long as they credit the Author(s) for the original creation.
Authors may however choose to have their work distributed under any of the Creative Commons licenses currently available by specifying their preferred license in the publication agreement. A description of the Creative Commons licenses is available here: https://creativecommons.org/licenses/
- Authors retain their copyright, including the right to subsequently publish or disseminate their work elsewhere, provided that they make reasonable efforts to ensure that the publication in Eureka is acknowledged.
- Authors agree to determine, prior to publication, whether it is necessary to obtain permissions from any third party who hold rights with respect to any photographs, illustrations, drawings, text, or any other material (“third party work”) to be published in connection with your work. Copyright permission will not be necessary if the use is determined to be fair dealing, if the work is in the public domain, or if the rights-holder has granted a Creative Commons or similar license.
- All co-authors and investigators (e.g. faculty supervisors) with claims to the intellectual property have read and signed the agreement, thereby providing their consent for the submission to be published in Eureka.
Unless otherwise specified, authors guarantee that all parts of the submission are the author’s original work. Submissions containing evidence of plagiarism will not be eligible for publication.